AOD-9604 is administered via subcutaneous injection into fatty tissue, with the abdominal region being the preferred site
Research overview Related protocols and comparisons BPC-157 (5 mg Vial) Dosage Protocol BPC-157 (10 mg Vial) Dosage Protocol BPC-157 + TB-500 (20 mg Blend) Dosage Protocol TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol Tri-Heal (45 mg Blend) Dosage Protocol GLOW (70 mg Blend) Dosage Protocol KLOW (80 mg Blend) Dosage Protocol TB-500 (5 mg Vial) Dosage Protocol
Increases SIRT-1 activity as a result of enhanced NAD+ salvage, leading to beneficial epigenetic and metabolic reprogramming, including increased oxidative phosphorylation (OXPHOS) and muscle stem cell activation 1-3
If you believe you may benefit from vitamin B12 injections, talk with your doctor
Bruno Jirgensons (19041982) was a very noticeable figure in the field of protein ORD, making significant contributions to the development and application of ORD as a technique for investigating the structure of proteins and other macromolecules (Jirgensons, 1964
65 However, as this was an open-label, uncontrolled trial, it is impossible to assess how much of the improvement was due to a placebo effect
